Eckart Bartnik

Inhibition of RIPK1 prevents keratinocyte cell death and reduces skin inflammation in type 1–mediated chronic inflammatory skin diseases

Manja Jargosch, Sophia Wasserer, Jessica Eigemann, Theresa Raunegger et autres

de, us (code pays fourni par la source)

The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: A potential disease-modifying OA drug

Sheona P. Drummond, Eckart Bartnik, Nikolaos Kouvatsos, Jenny L. Scott et autres

gb, de (code pays fourni par la source)

Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa

Robert Sabat, Deimantė Šimaitė, Jóhann E. Guðjónsson, Theresa-Charlotte Brembach et autres

de, us, fr (code pays fourni par la source)

The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: a potential disease-modifying OA drug

Sheona P. Drummond, Eckart Bartnik, Nikolaos Kouvatsos, Jenny L. Scott et autres

gb, de, us (code pays fourni par la source)

Activity and components of the granulocyte colony‐stimulating factor pathway in hidradenitis suppurativa*

Kerstin Wolk, Theresa-Charlotte Brembach, Deimantė Šimaitė, Eckart Bartnik et autres

de, fr (code pays fourni par la source)

Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells

Henrika Jodeleit, Paula Winkelmann, J Caesar, Sebastian Sterz et autres

de (code pays fourni par la source)

The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab

Henrika Jodeleit, J Caesar, C Villarroel Aguilera, Sebastian Sterz et autres

de (code pays fourni par la source)

381 Evaluation of pharmacological responses to subcutaneous injection of adalimumab in InflammaSkin®, a full-thickness human ex vivo skin model reproducing key features of psoriatic lesions

C. Jardet, Eckart Bartnik, Emilie Braun, Anthony S. David et autres

de (code pays fourni par la source)

Translational drug discovery and development with the use of tissue‐relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy

Peter Florian, K. Flechsenhar, Eckart Bartnik, Danping Ding‐Pfennigdorff et autres

de, us (code pays fourni par la source)

TSG-6 protects cartilage and bone by modulating the activities of chondrocytes and osteoclasts: a potential therapeutic for musculoskeletal disorders

Caroline M. Milner, Sheona P. Drummond, Ioannis Kanakis, Jenny L. Scott et autres

A novel chondroprotective property of TSG-6 has therapeutic potential for OA

Anthony J. Day, Sheona P. Drummond, Sanjay Anand, Eckart Bartnik et autres

gb, de (code pays fourni par la source)

Sample Size Calculations for Detecting Disease‐Modifying Osteoarthritis Drug Effects on Knee Replacement Incidence in Clinical Trials: Data From the Osteoarthritis Initiative

Janina S. Ried, K. Flechsenhar, Eckart Bartnik, Daniel Crowther et autres

de, at (code pays fourni par la source)